M&A Deal Summary

Elanco Acquires Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines

On October 5, 2016, Elanco acquired life science company Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines from Boehringer Ingelheim Vetmedica for 885M USD

Acquisition Highlights
  • This is Elanco’s 4th transaction in the Life Science sector.
  • This is Elanco’s 2nd largest (disclosed) transaction.
  • This is Elanco’s 4th transaction in the United States.
  • This is Elanco’s 1st transaction in Montana.

M&A Deal Summary
Date 2016-10-05
Target Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines
Sector Life Science
Buyer(s) Elanco
Sellers(s) Boehringer Ingelheim Vetmedica
Deal Type Divestiture
Deal Value 885M USD

Target

Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines

St. Joseph, Montana, United States
Boehringer Ingelheim Vetmedica, Inc. - U.S. Feline, Canine and Rabies Vaccines is a developer of vaccines for animals. The business also inculded fully integrated manufacturing and R&D site.

Search 193,724 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Elanco

Greenfield, Indiana, United States

website

Category Company
Founded 1954
Sector Life Science
Employees9,000
Revenue 4.4B USD (2022)
DESCRIPTION

Elanco develops and markets products and services to improve animal health and protein production in more than 75 countries. Elanco employs more than 3,000 people worldwide, with offices in more than 40 countries. Elanco was incorporated in 1954 and is based in Greenfield, Indiana.

DEAL STATS #
Overall 7 of 11
Sector (Life Science) 4 of 7
Type (Divestiture) 4 of 5
State (Montana) 1 of 1
Country (United States) 4 of 6
Year (2016) 1 of 1
Size (of disclosed) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-24 Lohman SE

Cuxhaven, Germany

Lohmann is a manufacturer of feed additives and poultry vaccines, selling its products in over 80 countries around the world. Headquartered in Cuxhaven, Germany, Lohmann has a production facility there, a vaccine plant in Winslow, Maine, and is represented by 18 subsidiaries in Europe, Asia and North America. The focus of Lohmann is the development of vaccines and food components that help prevent diseases of animals used in food production.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-26 Aratana Therapeutics

Leawood, Kansas, United States

Aratana Therapeutics, Inc. is a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, or pet therapeutics. Aratana Therapeutics, Inc. was formed in 2010 and is headquartered in Leawood, Kansas.

Buy $245M

Seller(S) 1

SELLER

Boehringer Ingelheim Vetmedica

St. Joseph, Montana, United States

website

Category Company
Founded 1917
Sector Life Science
DESCRIPTION

Boehringer Ingelheim Vetmedica, Inc. is a developer of innovative vaccines and pharmaceuticals with the highest therapeutic value in the cattle, equine, pet and swine markets.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Divestiture) 1 of 2
State (Montana) 1 of 2
Country (United States) 1 of 2
Year (2016) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-04 Boehringer Ingelheim Vetmedica - Cydectin

St. Joseph, Montana, United States

Boehringer Ingelheim Vetmedica, Inc. - Cydectin includes CYDECTIN Pour-On, CYDECTIN Injectable and CYDECTIN Oral Drench. These endectocides with the active ingredient moxidectin offer persistent killing of internal parasites at multiple stages, including the most economically devastating parasite, Ostertagia ostertagi (brown stomach worm) and controls external parasites including lice, grubs and psoroptic mange mites on beef and dairy cattle.

Sell -
Mergr

Product

Company

Legal